2026 NPPES data Specialist NPI 1922026590 MEDICAL OBGYN/MD
Verify on CMS →

LORI BLUVAS, MEDICAL OBGYN/MD

Specialist in REDWOOD CITY, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
32
Medicare Part D claims · Specialist avg: 1K
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$164.22
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LORI BLUVAS, MEDICAL OBGYN/MD filed 32 Medicare Part D claims in 2023 as a Specialist in REDWOOD CITY, California, prescribing 66% generic.

32
Part D claims, 2023
66%
generic prescribing
$164.22
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LORI BLUVAS, MEDICAL OBGYN/MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

32 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about LORI BLUVAS, MEDICAL OBGYN/MD?

Quality data not reported

NPI registry status

Active

Issued 07/18/2006

NPI 1922026590

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

32 98% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

Specialty distribution in California

How Specialist compares to other specialties among California providers

California providers

Specialist share within California

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Specialist ABMS/AOA estimate

Est. board-certified rate (Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LORI BLUVAS, MEDICAL OBGYN/MD appears in the CMS NPPES registry as a Specialist provider holding MEDICAL OBGYN/MD credentials at 401 WARREN ST, REDWOOD CITY, CA, 94063, with a listed phone of (650) 701-1882. NPI 1922026590 was issued on 07/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BLUVAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 32 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $2K in drug spend, split 34% brand-name and 66% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

401 WARREN ST
REDWOOD CITY, CA 94063

Provider Details

NPI 1922026590
Specialty Specialist
Credentials MEDICAL OBGYN/MD
Gender Female
NPI Issued 07/18/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LORI BLUVAS, MEDICAL OBGYN/MD. Source: openpaymentsdata.cms.gov.

Total received

$164

Largest payer

Ethicon US, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LORI BLUVAS, MEDICAL OBGYN/MD. To verify LORI BLUVAS, MEDICAL OBGYN/MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

LORI BLUVAS, MEDICAL OBGYN/MD — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 32 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

32
Total Claims
$2K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
42
Total Day Supply
1,024
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$1K
Generic Drug Cost
$389

Patient Demographics

Average Patient Age
68.8 years
Avg HCC Risk Score
0.64

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Nystatin
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How LORI BLUVAS, MEDICAL OBGYN/MD fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

LORI BLUVAS, MEDICAL OBGYN/MD's 32 claims are below the specialty average of 1,474.

Nearby Specialist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BLUVAS.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is LORI BLUVAS, MEDICAL OBGYN/MD's specialty?
LORI BLUVAS, MEDICAL OBGYN/MD specializes in Specialist and practices in REDWOOD CITY, California. Credentials: MEDICAL OBGYN/MD.
How much does LORI BLUVAS, MEDICAL OBGYN/MD prescribe under Medicare Part D?
In 2023, LORI BLUVAS, MEDICAL OBGYN/MD wrote 32 Medicare Part D claims totaling $2K in drug costs for N/A beneficiaries.
Where is LORI BLUVAS, MEDICAL OBGYN/MD located?
LORI BLUVAS, MEDICAL OBGYN/MD is located at 401 WARREN ST, REDWOOD CITY, CA, 94063. Phone: (650) 701-1882.
What is LORI BLUVAS, MEDICAL OBGYN/MD's NPI number?
LORI BLUVAS, MEDICAL OBGYN/MD's National Provider Identifier (NPI) is 1922026590, issued on 07/18/2006.
Does LORI BLUVAS, MEDICAL OBGYN/MD prescribe more brand-name or generic drugs?
LORI BLUVAS, MEDICAL OBGYN/MD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $1K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does LORI BLUVAS, MEDICAL OBGYN/MD prescribe most often?
Based on 2023 Medicare Part D data, LORI BLUVAS, MEDICAL OBGYN/MD's most frequently prescribed drugs include Nystatin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LORI BLUVAS, MEDICAL OBGYN/MD accept Medicare?
LORI BLUVAS, MEDICAL OBGYN/MD appears in CMS Medicare data with 32 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LORI BLUVAS, MEDICAL OBGYN/MD's credentials?
LORI BLUVAS, MEDICAL OBGYN/MD's NPI is 1922026590 with credentials MEDICAL OBGYN/MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology